The Ninth International AIDS Society Conference on HIV Science 2017
The Ninth International AIDS Society (IAS) Conference on HIV Science (IAS 2017) will be held 23-26 July 2017 at the Palais des Congrès in Paris, France. This biennial gathering is the largest open scientific conference on HIV and AIDS related issues – bringing together a broad cross-section of more than 6,000 professionals from around the world to meet and examine the latest scientific developments in HIV-related research with a focus on moving science into practice and policy.
The Elizabeth Glaser Pediatric AIDS Foundation (EGPAF) will be in attendance to share and learn at this event. EGPAF has been awarded the honor of three oral and 10 poster presentations (please see below, and feel free to click on the title of each to read our full abstracts). We will be hosting two satellite sessions at IAS 2017; one focusing on delivering uninterrupted services to adolescents and young adults and one on point-of-care early infant testing in resource-limited settings (please see below information on when and where these will be held). Please visit us at any and all of these presentations and events. We also invite you to stop by our booth in the exhibition center to learn more about our work in 6,000 sites across 19 countries.
Satellites and Workshops
Please join EGPAF, other global experts on adolescent health and a panel of youth advocates for a discussion on best approaches to deliver an uninterrupted continuum of comprehensive services to young people living with HIV. The goal of this satellite is to raise awareness and facilitate discourse on adolescent-specific needs as part of a comprehensive national HIV/AIDS care and treatment package. Experts from EGPAF, the U.S. Centers for Disease Control and Prevention (CDC), the Adolescent HIV Treatment Coalition, International AIDS Society and adolescent and youth advocates will review successes and challenges in testing, linkage to and retention in care and treatment from programmatic and adolescent perspectives.
With the availability of effective point-of-care (POC) molecular technology for diagnostics, ministries of health, along with partners, have begun to implement routine POC testing in an effort to optimize laboratory networks and improve clinical outcomes. This satellite session will feature presentations by ministry of health officials and partners. Topics covered will include deployment strategies, multiplexed POC testing devices to maximize throughput capacity, implementing routine POC testing to enhance early infant diagnosis (EID), the projected potential impacts of implementing World Health Organization recommendations for POC EID testing, and the use of connectivity for remote monitoring of decentralized testing networks.
EGPAF ambassador Josephine Kabukenya will be speaking. Dr. Lynne Mofenson, Senior HIV Technical Advisor of EGPAF’s Research Division is organizing this session.
Oral Abstract Sessions
Comparing conventional to point-of-care early infant diagnosis: pre- and post-intervention data from a multi-country evaluation.
Safety and efficacy of E/C/F/TAF in virologically suppressed, HIV-infected children through 48 weeks.
Shifting dynamics of HIV transmission timing among infants in the era of option B+ and implications for infant testing.
Prevention of mother-to-child transmission of HIV in an urban area of the USA: are we doing too much?
Use of digital gaming and Wisepill dispenser technology to measure adherence among HIV-infected adolescents and young adults.